Butterfly Network, Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 28, 2022 | national

0

GUILFORD, Connecticut and NEW YORK–(BUSINESS WIRE)–February 9, 2022–

Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care through wearable full-body ultrasound, announced that it will report fourth quarter and 2021 and will provide a business update in February. February 28, 2022, before market opening.

Dr. Todd Fruchterman, President and Chief Executive Officer, and Stephanie Fielding, Chief Financial Officer, will host a conference call and webcast at 8:30 a.m. ET on February 28, 2022, to discuss fourth quarter financial and operating results and the year 2021 progress.

The conference call will be broadcast live in a listen-only mode via webcast on Butterfly’s Investor Relations website at Events and presentations.

Those interested in listening to the conference call on your phone can do so by dialing approximately ten minutes before the start time:

National calls in the United States: 1 (888) 440-4052

Calls outside the United States: 1 (646) 960-0827

Please enter conference ID 9393576

Following the live webcast, the call will be archived on Butterfly’s Investor Relations page. Additionally, a telephone replay of the call will be available through March 7, 2022 at 11:59 p.m. ET by dialing 1 (800) 770-2030 or 1 (647) 362-9199 and referencing ID conference number 9393576.

About Butterfly Network, Inc.

Founded by Dr. Jonathan Rothberg in 2011 and recently listed on the New York Stock Exchange as part of a business combination with Longview Acquisition Corp., Butterfly has created the first portable single-probe body ultrasound system using semi- drivers, the Butterfly iQ+. Butterfly’s mission is to democratize medical imaging and contribute to the aspiration for global health equity, by making high quality ultrasound affordable, easy to use, globally accessible and intelligently connected. , including for the 4.7 billion people worldwide who do not have access to ultrasound. . With its proprietary Ultrasound-on-Chip™ technology, Butterfly is leading the way in early detection and remote management of health conditions worldwide. Butterfly iQ+ can be purchased online today by healthcare professionals in the United States, Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland and the United Kingdom.

Butterfly iQ+ is a prescription device intended for qualified healthcare professionals only.

For more information, visit www.butterflynetwork.com.

Show source version on businesswire.com:https://www.businesswire.com/news/home/20220209005797/en/

CONTACT: Investors

Agnes Lee

650.677.9138

[email protected]

holly spring

781.888.8219

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK CONNECTICUT

INDUSTRY KEYWORD: RADIOLOGY AUDIO/VIDEO EQUIPMENT GENERAL HEALTH HEALTH MEDICAL DEVICES SEMICONDUCTOR TECHNOLOGY

SOURCE: Butterfly Network, Inc.

Copyright BusinessWire 2022.

PUBLISHED: 02/09/2022 16:15 / DISK: 02/09/2022 16:17

http://www.businesswire.com/news/home/20220209005797/en

Copyright BusinessWire 2022.

Share.

About Author

Comments are closed.